短暂抑制集落刺激因子1受体后卒中后小胶质细胞再增殖的纵向18F-DPA-714 PET显像评估
研究采用短暂性大脑中动脉闭塞小鼠模型,治疗组于缺血后第3至7天给予CSF-1R抑制剂PLX5622(1,200 ppm饲料)诱导小胶质细胞/巨噬细胞耗竭后恢复对照饮食以允许再增殖。纵向18F-DPA-714(TSPO)PET/CT显示再增殖组梗死区示踪剂摄取在缺血后第14天(P < 0.001)和第21天(P = 0.002)显著升高,组织学与基因表达分析符合小胶质细胞再增殖特征,行为学测试显示治疗组第14天运动功能优于对照组。
要点
- 短暂CSF-1R抑制后撤药允许小胶质细胞再增殖,梗死区18F-DPA-714摄取在缺血后第14天和第21天显著升高。
- 再增殖组第14天Iba-1阳性细胞TSPO、CSF-1R和CD68表达显著升高,小胶质细胞相关基因csf-1r、aif1、p2ry12表达增加。
- PLX5622治疗组第14天行走距离更长(P < 0.001)、速度更快(P = 0.009)、前肢力量更强(P < 0.001)。
核心结论
- 本研究凸显了18F-DPA-714 PET/CT显像在卒中后短暂CSF-1R抑制后追踪小胶质细胞和巨噬细胞再增殖的潜力。
研究设计与样本
- 每组8只C57BL/6小鼠接受30分钟短暂性大脑中动脉闭塞。
- 治疗组于缺血后第3至7天给予含1,200 ppm PLX5622的饲料以诱导小胶质细胞/巨噬细胞耗竭,随后恢复对照饮食以允许再增殖。
- 小鼠于缺血后第1天行T2加权MRI,于第7、14、21、30天行18F-DPA-714(TSPO)PET/CT。
- 评估梗死区、对侧纹状体和脾脏的每毫升注射示踪剂剂量百分比,并行行为学测试评估运动功能恢复。
- 缺血后第14天和第35天取脑行离体分析(免疫反应性和实时定量聚合酶链反应)检测小胶质细胞和巨噬细胞相关标志物。
主要发现
- 再增殖组梗死区18F-DPA-714摄取在缺血后第14天(P < 0.001)和第21天(P = 0.002)显著升高。
- 第14天Iba-1阳性细胞群TSPO、CSF-1R和CD68表达显著升高,与小胶质细胞再增殖一致。
- 第14天基因表达分析显示再增殖组小胶质细胞相关标志物(csf-1r、aif1、p2ry12)显著增加,而外周细胞募集相关基因表达(cx3cr1、ccr2)下降,提示CSF-1R抑制期间存在外周募集。
- 未校正脾脏摄取在治疗组缺血后第7天显著升高(P = 0.001),撤药后下降。
- 第14天PLX5622治疗组较对照组行走距离更长(P < 0.001)、速度更快(P = 0.009)、前肢力量更强(P < 0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Studies on colony-stimulating factor 1 receptor (CSF-1R) inhibition-induced microglia depletion indicated that inhibitor withdrawal allowed the renewal of the microglia compartment via repopulation and resolved the inflammatory imbalance. Therefore, we investigated for the first time (to our knowledge) the effects of microglia repopulation on inflammation and functional outcomes in an ischemic mouse model using translocator protein (TSPO)-PET/CT and MR imaging, ex vivo characterization, and behavioral tests. Methods: Eight C57BL/6 mice per group underwent a 30-min transient occlusion of the middle cerebral artery. The treatment group received CSF-1R inhibitor in 1,200 ppm PLX5622 chow (Plexxikon Inc.) from days 3 to 7 to induce microglia/macrophage depletion and then went back to a control diet to allow repopulation. The mice underwent T2-weighted MRI on day 1 after ischemia and 18F-labeled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-α]pyrimidine-3-yl)acetamide (18F-DPA-714) (TSPO) PET/CT on days 7, 14, 21, and 30. The percentage injected tracer dose per milliliter within the infarct, contralateral striatum, and spleen was assessed. Behavioral tests were performed to assess motor function recovery. Brains were harvested on days 14 and 35 after ischemia for ex vivo analyses (immunoreactivity and real-time quantitative polymerase chain reaction) of microglia- and macrophage-related markers. Results: Repopulation significantly increased 18F-DPA-714 uptake within the infarct on days 14 (P < 0.001) and 21 (P = 0.002) after ischemia. On day 14, the ionized calcium binding adaptor molecule 1 (Iba-1)-positive cell population showed significantly higher expression of TSPO, CSF-1R, and CD68, in line with microglia repopulation. Gene expression analyses on day 14 indicated a significant increase in microglia-related markers (csf-1r, aif1, and p2ry12) with repopulation, whereas peripheral cell recruitment-related gene expression decreased (cx3cr1 and ccr2), indicative of peripheral recruitment during CSF-1R inhibition. Similarly, uncorrected spleen uptake was significantly higher on day 7 after ischemia with treatment (P = 0.001) and decreased after drug withdrawal. PLX5622-treated mice walked a longer distance (P < 0.001) and more quickly (P = 0.009), and showed greater forelimb strength (P < 0.001), than control mice on day 14. Conclusion: This study highlighted the potential of 18F-DPA-714 PET/CT imaging to track microglia and macrophage repopulation after short-term CSF-1R inhibition in stroke.
引用
- Barca C, Kiliaan AJ, Wachsmuth L, et al. Short-Term Colony-Stimulating Factor 1 Receptor Inhibition-Induced Repopulation After Stroke Assessed by Longitudinal 18F-DPA-714 PET Imaging. J Nucl Med. 2022. PMID: 35115368. doi:10.2967/jnumed.121.263004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。